Back to Industry News
General
Dexcom Restructures, Cuts 350 Jobs Globally
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Medtech Magazine
Photo by diabetesmagazijn.nl on Unsplash
Stay updated on stories like this
Key takeaways
- Medtech Magazine reports that Dexcom, a medical technology company specializing in diabetes management, is implementing a significant organizational restructuring
- This initiative will lead to the elimination of 350 positions globally, a workforce reduction representing approximately three percent of the company's total employee base
- The majority of these layoffs, exceeding fifty percent, will take place at Dexcom's corporate headquarters in San Diego, California
Medtech Magazine reports that Dexcom, a medical technology company specializing in diabetes management, is implementing a significant organizational restructuring. This initiative will lead to the elimination of 350 positions globally, a workforce reduction representing approximately three percent of the company's total employee base. The majority of these layoffs, exceeding fifty percent, will take place at Dexcom's corporate headquarters in San Diego, California. While Dexcom maintains international operations in countries such as Austria, Canada, Germany, Switzerland, and the United Kingdom, specific impacts in these regions were not detailed.
A Dexcom spokesperson explained that these job cuts are a direct result of fundamental changes to the company's organizational model and operational structure. This action follows a substantial savings initiative implemented by Dexcom last year, which resulted in the dismissal of over 500 employees. The current restructuring is positioned as a continuation of the company's ongoing efforts to refine its operational framework.
Related Topics
Dexcomlayoffsrestructuringmedical technologydiabetes sectorworkforce reduction
Never miss stories like this